Valeant Pharma (VRX) on Watch as Ahead of Pershing Square Conference Call

Down 7.6% currently, Valeant Pharma (NYSE: VRX) is on watch ahead of Bill Ackman's conference call, which is starting at 9:00AM ET.

During the call, Bill Ackman and other members of the Pershing Square investment team will address questions from investors e‐mailed to [email protected].

A live audio webcast of the conference call will be available to the public on PSH's website at www.pershingsquareholdings.com. The conference call will also be available by phone.

US Toll-Free Participant Event Plus Dial-In Number: (844) 489-4527
Participant International Dial-In Number: (925) 418-7826
Conference ID 69916104

This morning Valeant announced it has ended its controversial relationship with Philidor.

You May Also Be Interested In

• Trump on Iran: we're trying to work out a deal that's fair
• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Xerox Corp. (XRX) gains on report of SEWP VI contract